• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    Thea Pharma Statement Related to Akorn`s Recall of Various Human & Animal Drug

    PR NEWSWIRE

    In bid to sell to lenders, embattled Akorn files for bankruptcy

    FIERCE PHARMA

    Akorn Receives FDA Warning Letter

    GLOBENEWSWIRE

    FDA hits Akorn manufacturing facility with warning letter

    FIERCE PHARMA

    FDA Hands Akorn 483 Over GMP Issues at New Jersey Site

    RAPS

    Form 483 for Akorn’s Illinois Site Rekindles Questions on Fresenius Buyout

    US FDA issues Akorn with Form 483 after for Decatur plant

    IN PHARMATECHNOLOGIST

    Akorn U.S. sterile plant passes FDA reinspection

    FIERCE PHARMA

    FDA Sends Form 483 to Sterile Manufacturer Akorn Pharmaceuticals’ Illinois Plant

    RAPS

    FDA Drug Shortages: Sufentanil Citrate (Sufenta) Injection

    FDA

    FDA Drug Shortages: Fentanyl Citrate (Sublimaze) Injection

    FDA

    Akorn, Inc., Ongoing Class II recall of Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, in amber glass bottle with net fill weight of 16 g that provides 120 actuations, Rx only, Manufactured by HI-TECH PHARMACAL CO., INC. Amityville, NY 11701 for Akorn Inc. 1925 W. Field Court, Suite 300 Lake Forest Illinois, 60045. NDC 50383-700-16. because of Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride.

    FDA

    Akorn, Inc., Ongoing Class II recall of Erythromycin Pledgets USP, 2%, 60-count jar,Rx only, Manufactured by Ei LLC, Kannapolis, NC 28083, Marketed by VersaPharm Incorporated, Marietta, GA 30062, NDC 61748-202-60 . because of Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.